Global Amlodipine Besylate Market Size to Exceed USD 3.43 Billion by 2035 | CAGR of 7.12%
Category: HealthcareGlobal Amlodipine Besylate Market Size to Exceed USD 3.43 Billion by 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global Amlodipine Besylate Market Size is expected to Grow from USD 1.61 Billion in 2024 to USD 3.43 Billion by 2035, at a CAGR of 7.12% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Amlodipine Besylate Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Tablets, Capsules, and Others), By Application (Hypertension, Angina, Coronary Artery Disease, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/amlodipine-besylate-market
The global amlodipine besylate market involves the production, distribution, and sale of amlodipine besylate, a calcium channel blocker used to treat hypertension and angina. It lowers cardiovascular risks by relaxing blood vessels, improving blood flow. Widely prescribed worldwide, its effectiveness, affordability, and tolerability make it ideal for long-term hypertension management. Market growth is driven by increasing hypertension and cardiovascular disease prevalence, fueled by aging populations, sedentary lifestyles, and unhealthy diets. Rising cardiovascular health awareness and better healthcare access in emerging markets also boost demand. The availability of generic versions, following patent expirations, has made the drug more accessible. Opportunities exist in rural and developing regions where untreated hypertension remains common. The primary growth factor is the escalating global burden of hypertension and related conditions, with amlodipine besylate favored for its proven efficacy and cost-effectiveness as a generic medication. Market growth is limited by side effects, patient non-compliance, and competition from alternative antihypertensive drugs.
The tablets segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product type, the amlodipine besylate market is divided into tablets, capsules, and others. Among these, the tablets segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Tablet demand is rising as they remain the preferred form for treating hypertension and cardiovascular conditions. Innovations like sustained-release formulations further boost their popularity, enhancing patient compliance and supporting continued growth in the amlodipine besylate market.
The hypertension segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the amlodipine besylate market is divided into hypertension, angina, coronary artery disease, and others. Among these, the hypertension segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Amlodipine besylate is widely prescribed for hypertension due to its effectiveness and mild side effects. As awareness and diagnosis of this silent killer grow, the need for reliable antihypertensive treatments continues to rise globally.
The retail pharmacies segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the distribution channel, the amlodipine besylate market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. Among these, the retail pharmacies segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Retail pharmacies are likely to retain a strong market presence due to their accessibility and convenience for chronic medication needs. Expansion into rural and underserved regions by major chains further boosts growth in the amlodipine besylate market.
North America is expected to hold the majority share of the global amlodipine besylate market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global amlodipine besylate market during the forecast period. North America leads the global amlodipine besylate market due to a high cardiovascular disease burden, strong healthcare infrastructure, and high spending. The U.S. drives growth with many hypertension cases, major pharma companies, and access to advanced drug formulations.
Asia Pacific is anticipated to grow at the fastest pace in the global amlodipine besylate market during the forecast period. Asia Pacific is experiencing growth in the amlodipine besylate market due to rising hypertension and cardiovascular cases, especially in China and India. Improved healthcare infrastructure, higher spending, aging populations, and increasing awareness are driving demand and expanding access to treatment.
Major vendors in the global amlodipine besylate market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH, Cipla Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Pfizer Inc., Amneal Pharmaceuticals, Inc., Apotex Inc., Zydus Pharmaceuticals (USA) Inc., Alembic Pharmaceuticals Ltd., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In May 2025, Alembic Pharmaceuticals gained final USFDA approval for its ANDA of Amlodipine and Atorvastatin Tablets USP. This approved combination, used for managing hypertension and high cholesterol, is therapeutically equivalent to Caduet Tablets by Pharmacia and Upjohn Co. LLC.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the amlodipine besylate market based on the below-mentioned segments:
Global Amlodipine Besylate Market, By Product Type
- Tablets
- Capsules
- Others
Global Amlodipine Besylate Market, By Application
- Hypertension
- Angina
- Coronary Artery Disease
- Others
Global Amlodipine Besylate Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Amlodipine Besylate Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?